References
- Gugler R, Kreis L, Dengler HJ. Pharmacokinetics of a new adrenoceptor blocking agent, LF 17–895, in man. Arzneim Forsch (Drug Res.). 1975; 25: 1067–73.
- Krause W, Stoppelli I, Milia S et al. Transfer of mepindolol to newborns by breast-feeding mothers after single and repeated daily doses. Eur J Clin Pharmacol. 1982; 22: 53–5.
- Bonelli J. Hitzenberger G, Krause W et al. Pharmacokinetics and pharmacodynamics of mepindolol sulphate. Int J Clin Pharmacol Ther Toxicol. 1980; 18: 169–76.
- Balnave K, Neill JD, Russel CJ et al. Observations on the efficacy and pharmacokinetics of betaxolol (SL 75212), a cardioselective betaadrenoceptor blocking drug. Br J Clin Pharmacol. 1981; 11: 171 80.
- Guidicelli JF, Chavin M, Thuillez C; et al.Betaadrenoceptor blocking effect and pharmacokinetics of betaxolol (SL 75212) in man. Br J Clin Pharmacol. 1980; 10: 41–9.
- Jaillard J, Rouffy J, Sauvanet JP. Long-term influence of betaxolol on plasma lipids and lipoproteins. In Morselli, Kilborn, Cavero, Harrison, Larger (Eds). Betaxolol and other-adrenoceptor antagonists. L.E.R.S. Vol 1 221–31 (Raven Press 1983).
- Morselli PL, Thercelin JF, Padovani P et al. Comparative pharmacokinetics of several fiblockers in renal and hepatic insufficiency. In Morselli, Kilborn, Cavero, Harrison, Langer (Eds). Betaxolol and other,-adrenoceptor antagonists. L.E.R.S. Vol 1 233–42 (Raven Press 1983).
- Hughes FC, Julien D, Marche J. Influence of betaxolol and atenolol on airways in chronic obstructive lung diseases: Comparison with propranolol. In Morselli, Kilborn, Cavero, Harrison, Langer (Eds). Betaloxol and other J. adrenoceptor antagonists. L.E.R.S. Vol 1 195 203 (Raven Press 1983).
- Pathe M, Steimer C, Cazor JL et al. Doseresponse study of betaloxol in hypertension. J Morselli, Kilborn, Cavero, Harrison, Langer (Eds) Betaxolol and other in, adrenoceptor antagonists. L.E.R.S. Vol 1 287–96 (Raven Press 1983).
- de Backer G, Derese A. Double-blind study of betaxolol in patients with stable angina pectoris. In Morselli, Kilborn, Cavero, Harri son, Langer (Eds) Betaxolol and other,-adrenoceptor antagonists. L.E.R.S. Vol 1 2616. (Raven Press 1983).
- Bogers WAJL, Meems L. Endralazine, a new peripheral vasodilator. Evaluation of safety and efficacy over a 3 year period. Eur J Clin. Pharmacol. 1983; 24: 301–5.
- Wegmiiller E, Reubi FC. Changes in renal function induced by endralazine, a new antihypertensive drug. Eur J Clin Pharmacol 1983; 24: 307–14.
- Weber WW, Hein DW, Litwin A, Lower Jr GM. Relationship of acetylator status to isoniazid toxicity, lupus erythematosus and blad der cancer. Fed Proc. 1983; 42: 3086–97.
- Reece PA, Cozamanis I, Zacest R. A sensitive assay for endralazine and two of its metabo lites in human plasma. J Chromatogr. 1981; 225: 151–60.